2011 SPRING - Modelling Human Biology, Disease and Intervention

DATE, LOCATION & HOST

The spring 2011 PRISME Forum Technical Meeting was held Wednesday, May 4, 2011, and was hosted by Wellcome Trust at its conference center in Hinxton, Cambridge, UK.

The meeting was preceded by a group dinner on Tuesday, May 3, 2011.

PRISM Forum Technical Meeting Chair: James McGurk, Daiichi-Sankyo

PRISM Forum Chair: Susie Stephens, J&J

PRIME Forum Chair: Hilda Gibson, AstraZeneca

Wellcome Trust

Meeting hosted by Wellcome Trust

0-prisme-forum-sig-agenda-final-2011_05_03
Download
0.-PRISME-Forum-SIG-Agenda-Final-2011_05_03

3-prism-modspace-presentation-04may11
Download
3.-PRISM-Modspace-Presentation-04MAY113-prism-modspace-presentation-04may11
Download
3.-PRISM-Modspace-Presentation-04MAY11

4-selventa-prisme-presentation
Download
4.-Selventa-PRISME-presentation

5-ferdinand-rombout
Download
5.-Ferdinand-Rombout

7-modesim-prisme
Download
7.-MODESIM-PRISME

8-prism-presentaiton-0-3-1
Download
8.-PRISM-Presentaiton-0.3

9-disease-modeling-in-oncology-mj-04may11-prisme-ppt97
Download
9.-Disease-Modeling-in-Oncology-MJ-04MAY11-PRISMe-ppt97

10-friend-prisme-sig
Download
10.-Friend-PRISME-SIG

11-david-cook
Download
11.-David-Cook

2-mike-krams
Download
2.-Mike-Krams

AS PPTs:

Systems Biology for Product Testing – Julia Hoeng, Manager, PMI
Adaptive Designs for dose-finding: Background and Case Study: Mike Krams, VP – Head of Neurology Franchise at Johnson & Johnson
ModSPace: Analytical Knowledge Management – Richard Pugh, Technical Director and Co-Founder of Mango Solutions
Disease Modelling – Ewan Hunter – Product Manager and Snr. Technical Sales Consulant, Selventa
Cross Functional Modelling & Simulation – Ferdie Rombout – Director, DruDevO
Quantitative Systems Pharmacology Modeling to accelerate drug development a tale of SGLT2i FOR Type 2 Diabetes – Paul DaSilva-Jardine, VP Cardiovascular and Metabolic Diseases Biology, Pfizer
MODESIM (Modelling & SImulation at Novartis) – Paul Lewandowski, Associate Director Business Integration Manager, Novartis
MODESIM (Modelling & SImulation at Novartis) – Chris Bingham, Application Service Manager, Modelling & Simulation at Novartis
Drug/Disease Modelling & Simulation in Oncology – Mendel Jansen – Director, Translational Medicine & Clinical Pharmacology, Daiichi Sankyo
Modelling & Simulation in Systems Biology: The Way Forward – Stephen Friend, President, Co-Founder & Director of Sage Bionetworks
The Application of Systems Biology to Safety Assessment – David Cook, Associate Director, Global Safety Assessemnt, AstraZeneca